Prenetics Global (Prenetics Global) 3-Year Revenue Growth Rate : 251.90% (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global 3-Year Revenue Growth Rate?

Prenetics Global's Revenue per Share for the three months ended in Sep. 2023 was $0.41.

During the past 12 months, Prenetics Global's average Revenue per Share Growth Rate was 92.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 251.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 5 years, the highest 3-Year average Revenue per Share Growth Rate of Prenetics Global was 251.90% per year. The lowest was 251.90% per year. And the median was 251.90% per year.

Competitive Comparison of Prenetics Global's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Prenetics Global's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prenetics Global's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Prenetics Global's 3-Year Revenue Growth Rate falls into.

Prenetics Global 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Prenetics Global (NAS:PRE) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Prenetics Global 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Prenetics Global's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Prenetics Global (Prenetics Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG

Website

https://www.prenetics.com

Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.